#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	19	4940	16S	1529	1529	100.0	16S.l6.c4.ctg.1	2510	585.7	1	SNP	n	C1184T	0	.	.	1184	1184	C	1639	1639	C	723	C	622	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7756	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3880	599.4	0	.	n	.	0	G1337A	SNP	1337	1337	G	1861	1861	A	644	A,G	559,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7756	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3880	599.4	0	.	n	.	0	T1971C	SNP	1971	1971	T	2495	2495	C	717	C,A	633,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7756	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3880	599.4	1	SNP	n	A2045G	0	.	.	2045	2045	A	2569	2569	A	724	A,C	628,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	7756	23S	2890	2890	99.93	23S.l15.c4.ctg.1	3880	599.4	1	SNP	n	C2597T	0	.	.	2597	2597	C	3121	3121	C	692	C,T	599,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	824	folP	855	855	100.0	folP.l15.c4.ctg.1	1896	130.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1203	1205	AGC	174;174;174	A;G;C	150;152;155	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1600	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3717	129.1	1	SNP	p	S91F	0	.	.	271	273	TCC	757	759	TCC	171;170;172	T;C;C	142;142;146	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1600	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3717	129.1	1	SNP	p	D95G	0	.	.	283	285	GAC	769	771	GAC	173;172;171	G;A;C	149;147;145	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	1600	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3717	129.1	1	SNP	p	D95N	0	.	.	283	285	GAC	769	771	GAC	173;172;171	G;A;C	149;147;145	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	539	688	mtrR	633	633	99.21	mtrR.l6.c17.ctg.1	1646	125.4	0	.	p	.	0	A39T	NONSYN	115	117	GCC	621	623	ACC	163;163;163	A;C;C	139;138;138	.	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	539	688	mtrR	633	633	99.21	mtrR.l6.c17.ctg.1	1646	125.4	0	.	p	.	0	F88S	NONSYN	262	264	TTC	768	770	TCC	180;181;181	T,G;C;C,A	155,1;156;154,1	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	376	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c4.ctg.1	1335	84.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1722	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3308	156.0	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2274	2276	ATT	159;159;159	A;T;T	140;138;141	.	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1722	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3308	156.0	1	SNP	p	D86N	0	.	.	256	258	GAC	744	746	GAC	202;202;204	G;A;C	169;166;168	parC.WHO_V_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_V_00204c	parC.WHO_V_00204c	1	1	539	1722	parC	2304	2304	99.78	parC.l15.c4.ctg.1	3308	156.0	1	SNP	p	S88P	0	.	.	262	264	TCC	750	752	TCC	208;207;206	T;C;C	174;167;170	parC.WHO_V_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	1440	parE	1986	1986	99.9	parE.l15.c4.ctg.1	2872	150.2	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1644	1646	GGC	196;194;194	G;G;C	168;163;168	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.2.001	penA.2.001	1	1	27	1244	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2703	137.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1411	1413	GCA	203;202;199	G;C;A	173;174;171	penA.2.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1244	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2703	137.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1414	1416	ATC	198;196;193	A;T;C	170;168;168	penA.2.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1244	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2703	137.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1426	1428	GTG	200;199;201	G;T;G	175;173;173	penA.2.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1244	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2703	137.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1426	1428	GTG	200;199;201	G;T;G	175;173;173	penA.2.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1244	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2703	137.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1930	1932	ACC	144;144;144	A;C;C	132;132;132	penA.2.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1244	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2703	137.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1984	1986	GCG	153;154;154	G;CG,CGG;GC,GCC	125;98,1;98,1	penA.2.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1244	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2703	137.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1984	1986	GCG	153;154;154	G;CG,CGG;GC,GCC	125;98,1;98,1	penA.2.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1244	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2703	137.9	1	SNP	p	G543S	0	.	.	1627	1629	GGC	2107	2109	GGC	146;145;145	G;G;C	126;125;129	penA.2.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1244	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2703	137.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2116	2118	GGC	143;143;142	G;G;C	116;123;129	penA.2.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.2.001	penA.2.001	1	1	27	1244	penA	1749	1749	100.0	penA.l6.c30.ctg.1	2703	137.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2134	2136	CCG	144;144;145	C;C;G	117;124;120	penA.2.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	27	1650	ponA	2397	2397	99.96	ponA.l15.c4.ctg.1	3437	144.1	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1786	1788	CTG	183;182;183	C,A;T;G	158,1;156;157	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1018	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2138	143.0	0	.	p	.	0	S22G	NONSYN	64	66	AGC	583	585	GGC	223;221;222	G;G,C;C	194;192,1;193	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1018	porA	1146	1146	99.65	porA.l15.c4.ctg.1	2138	143.0	0	.	p	.	0	M83fs	FSHIFT	247	247	A	765	765	C	187	C,G	164,1	.	.
porB1a.WHO_G_02195c	porB1a.WHO_G_02195c	1	0	539	948	porB1a	984	984	99.9	porB1a.l15.c4.ctg.1	1883	150.4	0	.	p	.	0	G170S	NONSYN	508	510	GGC	991	993	AGC	214;214;214	A,G;G;C	189,2;189;187	.	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	3164	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	5193	182.8	1	SNP	p	H553N	0	.	.	1657	1659	CAT	2140	2142	CAT	178;178;178	C;A;T	153;151;149	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	460	rpsJ	312	312	100.0	rpsJ.l6.c30.ctg.1	1252	109.9	1	SNP	p	V57M	1	.	.	169	171	ATG	640	642	ATG	167;167;169	A;T;G	152;150;152	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
